Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 226,823 | 174,350 | 202,004 | 198,576 | 249,091 |
Marketable Securities | 454,702 | 477,606 | 422,391 | 387,910 | 269,078 |
Receivables | 45,353 | 104,866 | 147,515 | 131,118 | 174,242 |
Inventories | 53,088 | 57,693 | 59,446 | 102,609 | 73,979 |
TOTAL | $797,460 | $830,141 | $916,985 | $932,944 | $955,405 |
Non-Current Assets | |||||
PPE Net | 37,442 | 38,159 | 37,596 | 35,352 | 36,286 |
Intangibles | 2,039 | 2,038 | 2,006 | 1,835 | 1,958 |
Other Non-Current Assets | 99,491 | 99,584 | 29,263 | 29,206 | 29,350 |
TOTAL | $138,972 | $139,781 | $68,865 | $66,393 | $67,594 |
Total Assets | $936,432 | $969,922 | $985,850 | $999,337 | $1,022,999 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 3,246 | 7,296 | 3,211 | 3,050 | 4,959 |
Accrued Expenses | 37,466 | 32,988 | 35,494 | 42,509 | 37,824 |
Other current liabilities | 4,150 | 51,231 | 111,369 | 111,126 | 110,417 |
TOTAL | $44,862 | $91,515 | $150,074 | $244,080 | $345,198 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | 32,801 | N/A | N/A |
Deferred Revenues | N/A | N/A | N/A | 87,395 | 191,998 |
aiOther Non-Current Liabilities | 314,365 | 314,675 | 221,962 | 254,681 | 255,002 |
TOTAL | $314,365 | $314,675 | $254,763 | $254,681 | $255,002 |
Total Liabilities | $359,227 | $406,190 | $404,837 | $498,761 | $600,200 |
Shareholders' Equity | |||||
Shares Outstanding, K | 128,797 | 128,489 | 127,687 | 127,585 | 126,474 |
Common Shares | 129 | 128 | 128 | 127 | 126 |
Retained earnings | -945,096 | -948,527 | -924,195 | -991,928 | -1,055,737 |
Other shareholders' equity | -5,372 | -4,200 | -5,438 | -9,262 | -6,560 |
TOTAL | $577,205 | $563,732 | $581,013 | $500,576 | $422,799 |
Total Liabilities And Equity | $936,432 | $969,922 | $985,850 | $999,337 | $1,022,999 |